Advertisement

Brain Tumor Pathology

, Volume 18, Issue 2, pp 101–108 | Cite as

Primary lymphoma of the central nervous system: A clinicopathologic study

  • Eiji Taniguchi
Original Article

Abstract

We performed clinicopathologic examinations of 27 cases of primary lymphoma of the central nervous system not related to acquired immune deficiency syndrome. We considered age and change of performance status (PS) to be especially important in clinical examination. We also conducted pathological studies of these tumors and the characteristics of their cells, in order to characterize pathological subtypes, cell kinetics, and involvement of viruses. PS of patients more than 70 years old decreased markedly before treatment and did not show the improvement after treatment that was exhibited by those under 70 years of age. Low PS (60% or less) after initial treatment, high MIB-1 positivity (over 44.0%), and high counts of AgNOR (over 4.56/cell) were significantly associated with lower survival rates. Patients with immunoblastic lymphoma and high MIB-1 positivity are likely to die from general debilitation, without evidence of recurrence from imaging. Preoperative steroid therapy was significantly associated with higher apoptotic positivity.

Key words

CNS lymphoma MIB-1 Apoptosis Epstein-Barr virus 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Helle TL, Britt RH, Colby TV (1984) Primary lymphoma of the central nervous system. Clinicopathological study of experience at Stanford. J Neurosurg 60:94–103PubMedGoogle Scholar
  2. 2.
    CNS-Lymphoma Study Group, Japan (1992) CNS lymphoma-up to dateGoogle Scholar
  3. 3.
    Jellinger KA, Paulus W (1992) Primary central nervous system lymphoma—an update. J Cancer Res Clin Oncol 199:7–27CrossRefGoogle Scholar
  4. 4.
    Murray K, Kun L, Cox J (1986) Primary malignant lymphoma of the central nervous system. Results of treatment of 11 cases and review of the literature. J Neurosurg 65:600–607PubMedGoogle Scholar
  5. 5.
    Spaun E, Midholm S, Pedersen NT, et al (1985) Primary malignant lymphoma of the central nervous system. Surg Neurol 24:646PubMedCrossRefGoogle Scholar
  6. 6.
    Committee of Brain Tumor Registry of Japan (1999, Special report of brain tumor registry of Japan. Neurol Med Chir (Tokyo) 39:59–107Google Scholar
  7. 7.
    Eby NL, Grufferman S, Flannelly CM, et al (1988) Increased incidence of primary brain lymphoma in the US. Cancer 62:2461–2465PubMedCrossRefGoogle Scholar
  8. 8.
    Hochberg FH, Miller DC (1988) Primary central nervous system lymphoma. J Neurosurg 68:835–853PubMedCrossRefGoogle Scholar
  9. 9.
    O'Sullivan MG, Whittle IR, Gregor A, et al (1991) Increasing incidence of CNS primary malignant lymphoma in south-east Scotland. Lancet 338:895–896PubMedCrossRefGoogle Scholar
  10. 10.
    Schabet M (1999) Epidemiology of primary CNS lymphoma J Neuro-Oncol 43:199–201CrossRefGoogle Scholar
  11. 11.
    Karnofsky DA (1949) Evaluation of chemotherapy agents. Columbia University Press, New York, pp 191–205Google Scholar
  12. 12.
    Kinzler KW, Bigner SH, Bigner DD, et al (1987) Identification of an amplified, highly expressed gene in human glioma. Science 236:70–73PubMedGoogle Scholar
  13. 13.
    Crocker J, Nar P (1987) Nucleolar organizer regions in lymphoma. J Pathol 151:111–118PubMedCrossRefGoogle Scholar
  14. 14.
    Non-Hodgkin's Lymphoma Pathologic Classification Project (1982) National cancer institute sponsored study of classifications of non-Hodgkin's lymphomas—summary and description of a Working Formulation for clinical usage. Cancer 49:2112–2135CrossRefGoogle Scholar
  15. 15.
    Blay JY, Conroy T, Chevreau C, et al (1998) High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series. J Clin Oncol 16:864–871PubMedGoogle Scholar
  16. 16.
    Corry J, Smith JG, Wirth A, et al (1998) Primary central nervous system lymphoma: age and performance status are more important than treatment modality. Int J Radiat Oncol Biol Phys 41:615–620PubMedCrossRefGoogle Scholar
  17. 17.
    Abrey LE, DeAngelis LM, Yahalom J (1998) Long-term survival in primary CNS lymphoma. J Clin Oncol 16:859–63PubMedGoogle Scholar
  18. 18.
    DeAngelis LM (2000) Update on the management of primary CNS lymphoma. Oncology 14:228–234PubMedGoogle Scholar
  19. 19.
    Kiya K, Uozumi T, Kurisu K, et al (1991) Outcome of primary central nervous system lymphoma. Neurol Med Chir (Tokyo) 31:194–198CrossRefGoogle Scholar
  20. 20.
    Deckert-Schluter M, Rang A, Wiestler OD (1998) Apoptosis and apoptosis-related gene products in primary non-Hodgkin's lymphoma of the central nervous system. Acta Neuropathol 96:157–162PubMedCrossRefGoogle Scholar
  21. 21.
    Weller M (1999) Glucocorticoid treatment of primary CNS lymphoma. J Neuro-Oncol 43:237–239CrossRefGoogle Scholar
  22. 22.
    Nakagawa S, Shiraishi T, Kibara S, et al (1995) Detection of DNA strand breaks associated with apoptosis in human brain tumors. Virchows Arch 427:175–179PubMedCrossRefGoogle Scholar
  23. 23.
    Schiffer D, Cavalla P, Migheli A, et al (1995) Apoptosis and cell proliferation in human neuroepithelial tumors. Neurosci Lett 195:81–84PubMedCrossRefGoogle Scholar
  24. 24.
    Gabbai AA, Hochberg FH, Linggood RM, et al (1989) High-dose methotrexate for non-AIDS primary central nervous system lymphoma: report of 13 cases. J Neurosurg 70:190–194PubMedGoogle Scholar
  25. 25.
    De Luca A, Antinori A, Cingolani A, et al (1995) Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma. Br J Haematol 90:844–849PubMedGoogle Scholar
  26. 26.
    MacMahon EM, Glass JD, Hayward SD, et al (1991) Epstein-Barr virus in AIDS-related primary central nervous system lymphomas. Lancet 338:969–973PubMedCrossRefGoogle Scholar
  27. 27.
    Bashir R, Luca J, Cheloha K, et al (1993) Expression of Epstein-Barr virus proteins in primary CNS lymphoma in AIDS patients. Neurology 43:2358–2362PubMedGoogle Scholar
  28. 28.
    Bashir R, McManus B, Cunningham C, et al (1994) Detection of EBER-1 RNA in primary brain lymphomas in immunocompetent and immunocompromised patients. J Neurooncol 20:47–53PubMedCrossRefGoogle Scholar
  29. 29.
    DeAngelis LM, Wong E, Rosenblum M, et al (1992) Epstein-Barr virus in acquired immunodeficiency syndrome (AIDS) and non-AIDS primary central nervous system lymphoma. Cancer 70:1607–1611PubMedCrossRefGoogle Scholar
  30. 30.
    Paulus W, Jellinger K, Hallas C, et al (1993) Human herpesvirus-6 and Epstein-Barr virus genome in primary cerebral lymphomas. Neurology 43:1591–1593PubMedGoogle Scholar

Copyright information

© The Japan Society of Brain Tumor Pathology 2001

Authors and Affiliations

  • Eiji Taniguchi
    • 1
  1. 1.Department of NeurosurgeryNational Hospital Kure Medical CenterHiroshimaJapan

Personalised recommendations